BVT Aktienanleihe ABBN 28.03.2025/ DE000VD2T6H3 /
05/06/2024 19:56:11 | Diferencia+0.200 | Bid21:54:26 | Ask21:54:34 | Subyacente | Precio de ejercicio | Fecha de expiración | Tipo de opción |
---|---|---|---|---|---|---|---|
101.520EUR | +0.20% | - Volumen de oferta: - |
- Tamaño/ Volumen/ Formato de Ask: - |
ABB LTD N | 39.00 CHF | 28/03/2025 | Call |
GlobeNewswire
22:06
GDRX STOCKHOLDERS – Contact Robbins LLP for Information About the Pending Lead Plaintiff Deadline in...
GlobeNewswire
22:05
Revolution Medicines to Participate in Goldman Sachs 45th Annual Global Healthcare Conference
GlobeNewswire
22:05
Relay Therapeutics Announces Clinical Trial Collaboration with Pfizer to Evaluate Atirmociclib in Co...
GlobeNewswire
22:05
PowerUp Acquisition Corp. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly...
GlobeNewswire
22:05
ImmuCell Provides Update on Regulatory Status of Product Development Initiative for Re-Tain®
GlobeNewswire
22:05
QIAGEN launches digital PCR Assay Design Tool for QIAcuity, expands customization capabilities of it...
GlobeNewswire
22:01
Bruster's Real Ice Cream Donates Over 3,000 Sets of Pajamas to Foster Care Youth National Nonprofit,...
GlobeNewswire
22:01
Xenon Pharmaceuticals to Present at the Goldman Sachs 45th Annual Global Healthcare Conference
GlobeNewswire
22:01
Ventyx Biosciences Announces Positive Preclinical Data for CNS-Penetrant NLRP3 Inhibitor VTX3232 Dem...
GlobeNewswire
22:00
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
21:51
Brink's Prices $400 Million 5-Year and $400 Million 8-Year Senior Notes Offering
- Primera página
- Atrás
- 1
- 2
- 3
- 4
- Siguiente
- Última página